Authors
Loading...
Ephedrine-associated cardiovascular events warrant caution in at-risk patients; leaves open whether NO-targeted interventions modify risk in prospective studies.
Key points are not available for this paper at this time.
Dabisch et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: